usually very slow with a correspondingly good long-term prognosis. Most women with this disease have little extra disability during pregnancy and, owing to dilatation of the ureters in the later months, are able to pass large numbers of small renal calculi, often without great discomfort.
Nephrogenic diabetes insipidus: The prognosis of the hereditary form of this disease is dependent on early recognition of the abnormality. The diagnosis is usually made by finding severe hypernatremia and hyperchloremia in a male infant showing irritability and failure to thrive. Provided there has not been a long period of severe dehydration, the condition responds well to therapy with high water intake and the long-term prognosis is good. In neglected cases severe brain damage occurs, with irreversible mental deficiency. The prognosis in the acquired adult forms of the disease is dependent on that of the etiological condition, as satisfaction of thirst provides an instinctive method of correction of dehydration due to the polyuria. Treatment with thiazide diuretics lowers the urine volume and the resultant polydipsia, but does not reduce them to normal values.
Conclusion
Important advances are constantly being made in the understanding and management of renal tubular disorders but, as in many other branches of medicine, satisfactory control without irreversible severe disability often depends on early diagnosis. Some conditions, e.g. cystinosis, are still poorly understood, and therapy unfortunately remains unsatisfactory. Dr Frederick P Hudson (Alder Hey Children's Hospital, Liverpool)
Phenylketonuria
The distribution curve of the intelligence quotient of phenylketonuric (PKU) patients shows that the majority fall into the severely handicapped range, yet there is a puzzling tail reaching into the normal (Penrose 1951) , and the few with normal or near normal intelligence often have the same biochemical abnormality as those who are most handicapped. At one time the incidence of the disease was thought to be about 1 in 25,000, but the results of mass screening programmes conducted in the past three to four years and designed to detect PKU in the early weeks of life suggest that the incidence may be 1 in 10,000. This figure is based on over two and a half million tests done within the first ten days of life using bacterial inhibition method (Guthrie & Susi 1963) of estimating serum phenylalanine. The babies detected in this way are of course clinically normal at the time of diagnosis, and indeed it is unusual for the typical PKU infant to show any evidence of retarded development before the age of 6 months. It is reasonable to ask whether the change in the accepted incidence of PKU is due to an earlier faulty assessment, when most of the case finding was concentrated on patients of low intelligence, and whether there is really a much higher proportion of individuals than was originally thought, who have the biochemical abnormality of PKU yet are able to develop a normal, or near normal, intelligence. Another and very important explanation might be that not all these infants diagnosed as PKU by the screening tests are in fact suffering from that condition, and there may be variants of the classical disease which are not associated with severe mental retardation. This suggestion has been emphasized Section ofMedicine with Section ofPwdiatrics 1153 recently in Boston where 50 infants were detected by the Massachusetts State screening programme in a mere forty-eight months (Kennedy et al. 1967) . These are still unanswered questions but they are of considerable importance because we now recommend the use of an expensive and potentially dangerous diet for these apparentlynormal babies, which must be started in the early weeks of life and be continued for an indefinite period. Bickel et al. (1953) published the first report showing that a diet low in phenylalanine would correct the biochemical abnormalities in the typical PKU patient. The first patients were severely retarded and there was little or no improvement in their mental state. However, it was not long before reports appeared suggesting that babies starting treatment within the first six months or even the first year of life were able to develop normally or if not normal were certainly spared the devastating-mental subnormality usually associated with the disease. When treatment started within a few weeks of birth it was even more promising, and it seemed that early identification of the biochemical abnormality and institution of treatment might entirely prevent mental retardation.
These encouraging observations prompted the development of mass screening programmes for the early detection of the disease, and in many states in the USA a test is compulsory by law. In this country the Ministry of Health recommends Local Health Authorities to use the Phenistix test and although many cases have been found by this method it seems that for each one discovered about two have been missed until they presented with mental retardation. The apparent simplicity of this test is misleading and is to some extent responsible for the disappointing results. Other methods using samples of blood or urine absorbed on filter paper are being investigated, not primarily from the aspect of laboratory technology but rather to determine acceptability to the public and administrative convenience.
When a screening test gives a positive result it is essential to confirm the diagnosis by full biochemical investigation before treatment is started, but to wait until symptoms of retarded development appear would be quite wrong, in the light of present knowledge. Unfortunately this rules out a controlled trial to assess the value of treatment when started early in infancy; it is only possible to observe the effect of the diet on a highly selected group of patients and compare their development with untreated patients who have presented with mental retardation at a later age.
The absence of controlled trials and the publication of some rather exaggerated claims in early reports stimulated Bessman (1966) to complain that the legislation in the USA making a screening test compulsory was not backed by scientific evidence to show that the results of early treatment would justify these tests. Birch & Tizard (1967) discuss the results of treatment published by one group of workers in America and suggest that according to their published results the benefit of early treatment, contrary to the claim of the original authors, is still unproven.
When treatment is started after mental retardation has become obvious the result for any individual is uncertain; a few will improve, but many will not: nevertheless an attempt is usually worth while. When treatment can be started within the first three months of life the result is seldom disappointing. With the low phenylalanine protein foods and the vitamin and mineral supplements commercially available there is no reason why the nutrition of patients on the low phenylalanine diet should be other than excellent, and intellectual development is generally within normal limits. Fifteen patients seen at Alder Hey Hospital started treatment before the age of 8 weeks. All are outwardly normal children with IQs ranging from 75 to 114. The bald statement of IQ score gives only part of the picture. Two patients, with scores of 80 and 75, are brothers. Their father is a labourer. Until recently they lived in a small prefabricated dwelling along with two older brothers, one normal and in the C stream at school, and the other a PKU idiot who demanded a lot of time from his mother and who can hardly have been a good influence on two young developing minds. A girl now aged 8 has an IQ of 80, and a bright lively personality; she has a PKU sister (untreated) with IQ 46, and a nonphenylketonuric sister (IQ 63) and brother (IQ 104). For these three patients the IQ score of around 80 must be regarded as reasonably satisfactory considering the family and social backgrounds. When considering the results of treatmentitisessentialto take into account normal variations of score with age and different methods of testing. Testing of one Liverpool patient at approximately yearly intervals gave the following results: Ruth Griffiths' scale, 107, 84, 82; Merril-Palmer 73, 76; WISC 68, 79, 73, 88. Some low results were depressed by poor verbal perforrnance, probably reflecting the intellectual poverty of his home; there was improvement in his speech after he started school, even though he returned to normal diet soon after his fifth birthday. If the benefits of treatment are to be accurately assessed it is essential to consider each child's attainments in the light of what he might have been expected to achieve in his own family and social environment. Further tests to define social maturity, and concentration and learning powers must be added to the assessment of IQ. Comparisons with parents and siblings must be made. This is being attempted, but the numbers are few and the patients too young for any conclusion.
Recent reports from America give encouraging results, though most of the early treated cases are not yet 3 years old. In Los Angeles 15 such patients have an average development quotient of 100 (Koch et al. 1967) . In Boston 19 have DQ ranging from 80 to 136 (Kennedy et al. 1967 ). In Cincinnati 8 early treated cases have an average DQ 108, the mean score for unaffected siblings being 106, and for parents 109 (Berry et al. 1967 ). Sutherland et al. (1966 write: 'The very nature of the low phenylalanine regimen ... sets the child apart as "special": special food, special blood and urine tests, special visits to the doctor, and the special watchful and over-protective eye of the parent and teacher.... He may well fall short of fulfillment of his intellectual potential because of the problems the regimen creates.'
These problems increase as the child grows and becomes aware of the food his normal siblings are enjoying and it would obviously be a great relief to allow resumption of normal diet at school age. As the biochemical abnormality is a life-long affliction there would seem to be no justification for doing this. Dare one hope that if the brain is spared the biochemical abnormalities during the early years of development it will continue to function normally even if the abnormalities are allowed to return ?
The oldest patient still on treatment in Liverpool is now 8 years old and his very sensible mother has brought him up to accept his disability and restrictions and there is at present no question of discontinuing his diet. He is doing well in school and his IQ is 105. Four children with intelligence quotients just within the normal range, after treatment for three years in one case and five years in the other three, have returned to normal diet for periods ranging from two to four and a half years (Hudson 1966) . All now have raised serum phenylalanine levels and excrete phenylketones in the urine. None has shown outward evidence of mental disturbance. They are not irritable or hyperkinetic and there is no sign of diminishing attention span. IQ measurements have shown no fall in 3; the fourth has not been available for adequate testing. Three are in school and are reported to be co-operative and show reasonable learning ability. The EEG of 3 has remained normal, one developed an irritable spike focus and as a precaution is now taking an anticonvulsant. There are reports in the literature of several other children who have resumed normal diet, and most of these who started treatment early and have developed normally seem to be unharmed during the relatively short period of follow up. In spite of these hopeful observations it still seems advisable to continue with the low phenylalanine diet, provided it is possible to do so without imposing irksome and damaging restrictions on the child's mental and physical activities. It is much too early to say whether the padiatrician will pass his patients to the adult physician for continued treatment, but certainly those who are treated in childhood, whether they continue the diet or resume normal diet, will merit careful observation and assessment for many years.
The literature on the subject of the phenylketonuric woman who becomes pregnant is confusing. A number of children have been born to PKU women of reasonable intelligence and at least one-third of these, while not inheriting the metabolic disorder, have been mentally retarded, yet other offspring have developed normally. Possibly the level of phenylalanine during pregnancy helps to determine the outcome, but insufficient observations have yet been made. It is likely that the enzyme system for the conversion of phenylalanine to tyrosine only becomes operative after birth, and it therefore seems desirable to prevent the foetus from the possible'damaging effects of maternal hyperphenylalanemia, and the only solution is to persuade the pregnant phenylketonuric woman to take a low phenylalanine diet. Forbes et al. (1966) attempted to do this. Their patient was an untreated phenylketonuric aged 25 with an IQ of 96. She had two young children who seemed slightly letarded, each having a development quotient of 78 by the Gesell method of testing. In her third pregnancy the situation was explained to her and treatment was attempted with the low phenylalanine preparation Lofenalac. Unfortunately the diet proved unacceptable and was abandoned. At 10 months of age the third child had a DQ of 72.
Dr J D Allan of Macclesfield (personal communication) succeeded in giving a low phenylalanine diet (using Albumaid XP) to a pregnant PKU mother. The mother was aged 27, her IQ was 66 and her serum phenylalanine 27 mg/100 ml. She had three children; all were to some degree retarded, with IQ scores 56, 88, 52. Treatment was started in the fourth month of the pregnancy; she had previously tried the diet when not pregnant. Satisfactory serum phenylalanine levels were obtained during treatment. The baby weighed 3,068 g at birth and at the age of 1 year appears to be normal. Allan has demonstrated that it is possible to administer a low phenyl-alanine diet during pregnancy and maintain adequate nutrition of mother and foetus.
Phenylketonuria was identified just over thirty years ago, dietary treatment was started thirteen years ago, and screening for the identification of the disease in the young infant, though started in a few small areas in this country nearly ten years ago, has only been in operation on a large scale for three or four years. There is still much to be learned about PKU, but while knowledge is growing it is essential to identify and treat those infants who show biochemical abnormalities which we believe are usually the cause of severe mental retardation.
